SCHEMBL8377387

SCHEMBL8377387

CC(C)c1c(OCCN(C=O)OC(C)(C)C)noc1-c1ccc(F)cc1F

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377392 0.83 PPARD (0.33)
SCHEMBL8377411 0.81 TSHR (0.31)
SCHEMBL8376446 0.79 MAPT (0.31)
SCHEMBL8375800 0.78 ALDH1A1 (0.33)
SCHEMBL8380155 0.78 ACKR3 (0.36)
Hydrochloric Acid SCHEMBL8378895 0.78 ALOX5AP (0.33) KCNH2
SCHEMBL8375679 0.77 NPC1 (0.31)
SCHEMBL8378808 0.77 CHRNB2 (0.33)
SCHEMBL8377384 0.76 SCN9A (0.41)
SCHEMBL8377358 0.73 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed